1. Home
  2. HCVI vs ME Comparison

HCVI vs ME Comparison

Compare HCVI & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCVI
  • ME
  • Stock Information
  • Founded
  • HCVI 2021
  • ME 2006
  • Country
  • HCVI United States
  • ME United States
  • Employees
  • HCVI N/A
  • ME N/A
  • Industry
  • HCVI Blank Checks
  • ME Precision Instruments
  • Sector
  • HCVI Finance
  • ME Health Care
  • Exchange
  • HCVI Nasdaq
  • ME Nasdaq
  • Market Cap
  • HCVI 176.6M
  • ME 168.9M
  • IPO Year
  • HCVI 2021
  • ME N/A
  • Fundamental
  • Price
  • HCVI $10.62
  • ME $0.30
  • Analyst Decision
  • HCVI
  • ME Hold
  • Analyst Count
  • HCVI 0
  • ME 1
  • Target Price
  • HCVI N/A
  • ME $0.47
  • AVG Volume (30 Days)
  • HCVI 24.6K
  • ME 2.6M
  • Earning Date
  • HCVI 01-01-0001
  • ME 11-06-2024
  • Dividend Yield
  • HCVI N/A
  • ME N/A
  • EPS Growth
  • HCVI N/A
  • ME N/A
  • EPS
  • HCVI N/A
  • ME N/A
  • Revenue
  • HCVI N/A
  • ME $199,188,000.00
  • Revenue This Year
  • HCVI N/A
  • ME $0.05
  • Revenue Next Year
  • HCVI N/A
  • ME $17.98
  • P/E Ratio
  • HCVI N/A
  • ME N/A
  • Revenue Growth
  • HCVI N/A
  • ME N/A
  • 52 Week Low
  • HCVI $10.30
  • ME $0.30
  • 52 Week High
  • HCVI $11.47
  • ME $1.16
  • Technical
  • Relative Strength Index (RSI)
  • HCVI 49.55
  • ME 34.11
  • Support Level
  • HCVI $10.62
  • ME $0.30
  • Resistance Level
  • HCVI $10.66
  • ME $0.32
  • Average True Range (ATR)
  • HCVI 0.01
  • ME 0.02
  • MACD
  • HCVI -0.00
  • ME 0.00
  • Stochastic Oscillator
  • HCVI 33.33
  • ME 0.00

About HCVI Hennessy Capital Investment Corp. VI

Hennessy Capital Investment Corp VI is a shell company.

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

Share on Social Networks: